Browsing by Author Houser, Mark

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2014The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathyPerkovic, Vlado; Andress, Dennis; Brennan, John J; Coll, Blai; Correa-Rotter, R; de Zeeuw, Dick; et al, Various; Houser, Mark; Kohan, Donald; Lambers Heerspink, Hiddo; Makino, Hirofumi; Tang, Hui; The George Institute for Global HealthThe endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy, Journal of the American Society of Nephrology, vol.25, 5, 2014,pp 1083-1093
2017Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled TrialPerkovic, Vlado; Andress, Dennis; Brennan, John J; Coll, Blai; Correa-Rotter, R; et al, Various; Heerspink, Hiddo Lambers; Houser, Mark; Kohan, Donald; Makino, Hirofumi; Pritchett, Yili; Webb, David J.; The George Institute for Global HealthLongitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial, Drugs in R and D, vol.17, 3, 2017,pp 441-448